234 related articles for article (PubMed ID: 32412961)
1. Measuring LDL-cholesterol: what is the best way to do it?
Wolska A; Remaley AT
Curr Opin Cardiol; 2020 Jul; 35(4):405-411. PubMed ID: 32412961
[TBL] [Abstract][Full Text] [Related]
2. Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options.
Berman AN; Blankstein R
Curr Cardiol Rep; 2019 Aug; 21(9):110. PubMed ID: 31378838
[TBL] [Abstract][Full Text] [Related]
3. Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment.
Carr SS; Hooper AJ; Sullivan DR; Burnett JR
Pathology; 2019 Feb; 51(2):148-154. PubMed ID: 30595507
[TBL] [Abstract][Full Text] [Related]
4. Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group.
Wilson PWF; Jacobson TA; Martin SS; Jackson EJ; Le NA; Davidson MH; Vesper HW; Frikke-Schmidt R; Ballantyne CM; Remaley AT
J Clin Lipidol; 2021; 15(5):629-648. PubMed ID: 34802986
[TBL] [Abstract][Full Text] [Related]
5. Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study.
Ikezaki H; Lim E; Cupples LA; Liu CT; Asztalos BF; Schaefer EJ
J Am Heart Assoc; 2021 Feb; 10(5):e019140. PubMed ID: 33586462
[TBL] [Abstract][Full Text] [Related]
6. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Rosenblit PD
Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
[TBL] [Abstract][Full Text] [Related]
7. A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test.
Sampson M; Wolska A; Warnick R; Lucero D; Remaley AT
Clin Chem; 2021 Jul; 67(7):987-997. PubMed ID: 33876239
[TBL] [Abstract][Full Text] [Related]
8. World Heart Federation Cholesterol Roadmap 2022.
Ray KK; Ference BA; Séverin T; Blom D; Nicholls SJ; Shiba MH; Almahmeed W; Alonso R; Daccord M; Ezhov M; Olmo RF; Jankowski P; Lanas F; Mehta R; Puri R; Wong ND; Wood D; Zhao D; Gidding SS; Virani SS; Lloyd-Jones D; Pinto F; Perel P; Santos RD
Glob Heart; 2022; 17(1):75. PubMed ID: 36382159
[TBL] [Abstract][Full Text] [Related]
9. Treatment and Low-Density Lipoprotein Cholesterol Management in Patients Diagnosed With Clinical Atherosclerotic Cardiovascular Disease in Alberta.
Chen G; Farris MS; Cowling T; Colgan SM; Xiang P; Pericleous L; Rogoza RM; Tai MH; Anderson T
Can J Cardiol; 2019 Jul; 35(7):884-891. PubMed ID: 31292087
[TBL] [Abstract][Full Text] [Related]
10. Structure-based mechanism and inhibition of cholesteryl ester transfer protein.
Xue H; Zhang M; Liu J; Wang J; Ren G
Curr Atheroscler Rep; 2023 Apr; 25(4):155-166. PubMed ID: 36881278
[TBL] [Abstract][Full Text] [Related]
11. A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia.
Sampson M; Ling C; Sun Q; Harb R; Ashmaig M; Warnick R; Sethi A; Fleming JK; Otvos JD; Meeusen JW; Delaney SR; Jaffe AS; Shamburek R; Amar M; Remaley AT
JAMA Cardiol; 2020 May; 5(5):540-548. PubMed ID: 32101259
[TBL] [Abstract][Full Text] [Related]
12. National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report.
Jacobson TA; Ito MK; Maki KC; Orringer CE; Bays HE; Jones PH; McKenney JM; Grundy SM; Gill EA; Wild RA; Wilson DP; Brown WV
J Clin Lipidol; 2015; 9(2):129-69. PubMed ID: 25911072
[TBL] [Abstract][Full Text] [Related]
13. Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement in High-Cardiovascular-Risk Patients in Fuzhou, China.
Wang X; He Y; Wang T; Li C; Ma Z; Zhang H; Ma H; Zhao H
J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):307-315. PubMed ID: 31918567
[TBL] [Abstract][Full Text] [Related]
14. Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors.
Dansinger ML; Williams PT; Superko HR; Schaefer EJ
Lipids Health Dis; 2019 Jul; 18(1):154. PubMed ID: 31311555
[TBL] [Abstract][Full Text] [Related]
15. Measurement of Serum Low Density Lipoprotein Cholesterol and Triglyceride-Rich Remnant Cholesterol as Independent Predictors of Atherosclerotic Cardiovascular Disease: Possibilities and Limitations.
Lütjohann D; Klör HU; Stellaard F
Nutrients; 2023 May; 15(9):. PubMed ID: 37432317
[TBL] [Abstract][Full Text] [Related]
16. Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.
Duncan MS; Vasan RS; Xanthakis V
J Am Heart Assoc; 2019 Jun; 8(11):e011433. PubMed ID: 31137992
[TBL] [Abstract][Full Text] [Related]
17. Comparability of 11 different equations for estimating LDL cholesterol on different analysers.
Rossouw HM; Nagel SE; Pillay TS
Clin Chem Lab Med; 2021 Nov; 59(12):1930-1943. PubMed ID: 34384146
[TBL] [Abstract][Full Text] [Related]
18. Remnants, LDL, and the Quantification of Lipoprotein-Associated Risk in Atherosclerotic Cardiovascular Disease.
Packard CJ
Curr Atheroscler Rep; 2022 Mar; 24(3):133-142. PubMed ID: 35175548
[TBL] [Abstract][Full Text] [Related]
19. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
